Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Groupe ServioBio was a prominent European distributor of point-of-care diagnostic tests, primarily serving hospitals and emergency clinics in France and Germany. The company gained significant recognition in the late 2000s for its role in launching and distributing the VACCI-TEST-Tetanus (Tetanus Quick Stick) in partnership with the Canadian firm Vacci-Test Corporation. As a specialized distributor, it focused on rapid diagnostic solutions that provided immediate results in clinical settings. While it was once considered one of Europe's largest distributors in its niche, the company's independent operations appear to have ceased or been absorbed into larger entities in the years following its peak activity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Groupe ServioBio.